Geron
GERN
#6273
Rank
A$1.26 B
Marketcap
A$1.98
Share price
-1.48%
Change (1 day)
-62.98%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -A$72.15 Million

According to Geron's latest financial reports the company's current earnings are A$0.18 Billion. In 2024 the company made an earning of -A$0.24 Billion, an increase over its 2023 earnings that were of -A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$72.15 Million-68.94%
2024 -A$0.24 Billion-11.23%
2023 -A$0.27 Billion30.22%
2022 -A$0.21 Billion20.15%
2021 -A$0.17 Billion50.08%
2020 -A$0.12 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$46.26 Million8.84%
2017 -A$42.5 Million-3.08%
2016 -A$43.85 Million-22080.6%
2015 A$0.19 M-100.38%
2014 -A$52.98 Million-7.14%
2013 -A$57.05 Million
2011 -A$0.14 Billion19.04%
2010 -A$0.12 Billion8.45%
2009 -A$0.11 Billion-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$93.54 Million32.68%
2006 -A$70.5 Million25.59%
2005 -A$56.14 Million4.36%
2004 -A$53.79 Million19.73%
2003 -A$44.93 Million-15.46%
2002 -A$53.14 Million1.94%
2001 -A$52.13 Million33.59%
2000 -A$39.02 Million27.53%
1999 -A$30.6 Million63.13%
1998 -A$18.76 Million15.6%
1997 -A$16.23 Million-10.66%
1996 -A$18.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-A$14.13 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.71 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.36 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$0.11 Billion 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA